Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
20.0%
% of HRTS's 41 holdings also in THNR
34.8%
% of THNR's 23 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus THNR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.9% | 17.3% | 10.9% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% | 4.7% | 2.8% |
|
MERCK & CO. INC. | 2.5% | 4.5% | 2.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 2.3% | 6.1% | 2.3% |
|
AMGEN INC | 1.7% | 4.9% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to THNR
|
UNITEDHEALTH GROUP INC | 5.6% |
|
BRIDGEBIO PHARMA, INC. | 4.3% |
|
ABBOTT LABORATORIES | 4.0% |
 |
ASTRAZENECA PLC | 4.0% |
 |
NOVO NORDISK A/S-B | 3.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
GILEAD SCIENCES INC | 3.1% |
|
NOVARTIS AG | 3.1% |
|
BOSTON SCIENTIFIC CORP | 3.1% |
HRTS Underweight Relative to THNR
|
NOVO-NORDISK A/S-SPONS ADR | -12.6% |
|
ELI LILLY & CO | -6.3% |
 |
INNOVENT BIOLOGICS, INC. | -5.5% |
|
ROCHE HOLDING LTD | -5.0% |
|
ASTRAZENECA PLC-SPONS ADR | -4.9% |
|
PFIZER INC | -4.8% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.6% |
|
WEST PHARMACEUTICAL SERVICES | -4.1% |
|
CHUGAI PHARMACEUTICAL CO LTD | -3.8% |
|
HIMS & HERS HEALTH, INC. CLASS A | -3.7% |